OBJECTIVES: To investigate associated dimensions of fatigue regarding cognitive impairment, psychomotor performances, muscular effort power and circulating cytokine levels and their relations to symptom intensity in a sample of pure chronic fatigue syndrome (CFS) patients without overlapping objective sleepiness or sleep disorders. METHODS: 16 CFS patients were compared to 14 matched controls. We assessed structured symptom-scales, polysomnography, multiple sleep latency tests, attention (Zazzo-Cancellation ZCT, digit-symbol-substitution DSST), psychomotor vigilance and speed (PVT, finger tapping test, FTT), dynamometer handgrip force (tonic and phasic trials) and circulating cytokines (IFN-γ, IL-1b, IL-6, IL-8, IL-10, TNF-α). RESULTS: In addition to fatigue, CFS patients presented with higher affective symptom intensity and worse perceived sleep quality. Polysomnography showed more slow-wave sleep and microarousals in CFS but similar sleep time, efficiency and light-sleep durations than controls. Patients presented with impaired attention (DSST, ZCT), slower reaction times (PVT) but not with lower hit rates (FTT). Notwithstanding lower grip strength during tonic and phasic trials, CFS also presented with higher fatigability during phasic trials. Cytokine levels were increased for IL-1b, IL-8, IL-10 and TNF-α and fatigue intensity was correlated to grip strength and IL-8. CONCLUSIONS: In contrast to sleepiness, chronic fatigue is a more complex phenomenon that cannot be reduced to one single measured dimension (i.e., sleep propensity). Showing its relations to different measurements, our study reflects this multidimensionality, in a psychosomatic disorder such as CFS. To obtain objective information, routine assessments of fatigue should rule out sleepiness, combine aspects of mental and physical fatigue and focus on fatigability.
OBJECTIVES: To investigate associated dimensions of fatigue regarding cognitive impairment, psychomotor performances, muscular effort power and circulating cytokine levels and their relations to symptom intensity in a sample of pure chronic fatigue syndrome (CFS) patients without overlapping objective sleepiness or sleep disorders. METHODS: 16 CFS patients were compared to 14 matched controls. We assessed structured symptom-scales, polysomnography, multiple sleep latency tests, attention (Zazzo-Cancellation ZCT, digit-symbol-substitution DSST), psychomotor vigilance and speed (PVT, finger tapping test, FTT), dynamometer handgrip force (tonic and phasic trials) and circulating cytokines (IFN-γ, IL-1b, IL-6, IL-8, IL-10, TNF-α). RESULTS: In addition to fatigue, CFS patients presented with higher affective symptom intensity and worse perceived sleep quality. Polysomnography showed more slow-wave sleep and microarousals in CFS but similar sleep time, efficiency and light-sleep durations than controls. Patients presented with impaired attention (DSST, ZCT), slower reaction times (PVT) but not with lower hit rates (FTT). Notwithstanding lower grip strength during tonic and phasic trials, CFS also presented with higher fatigability during phasic trials. Cytokine levels were increased for IL-1b, IL-8, IL-10 and TNF-α and fatigue intensity was correlated to grip strength and IL-8. CONCLUSIONS: In contrast to sleepiness, chronic fatigue is a more complex phenomenon that cannot be reduced to one single measured dimension (i.e., sleep propensity). Showing its relations to different measurements, our study reflects this multidimensionality, in a psychosomatic disorder such as CFS. To obtain objective information, routine assessments of fatigue should rule out sleepiness, combine aspects of mental and physical fatigue and focus on fatigability.
Authors: C Fabrigoule; I Rouch; A Taberly; L Letenneur; D Commenges; J M Mazaux; J M Orgogozo; J F Dartigues Journal: Brain Date: 1998-01 Impact factor: 13.501
Authors: Andrea T White; Alan R Light; Ronald W Hughen; Lucinda Bateman; Thomas B Martins; Harry R Hill; Kathleen C Light Journal: Psychophysiology Date: 2010-03-04 Impact factor: 4.016
Authors: Daniel Neu; Hendrik Kajosch; Philippe Peigneux; Paul Verbanck; Paul Linkowski; Olivier Le Bon Journal: Psychiatry Res Date: 2010-12-31 Impact factor: 3.222
Authors: M Robinson; S R Gray; M S Watson; G Kennedy; A Hill; J J F Belch; M A Nimmo Journal: Scand J Med Sci Sports Date: 2009-04-13 Impact factor: 4.221
Authors: Kamaldeep S Bhui; Sokratis Dinos; Deborah Ashby; James Nazroo; Simon Wessely; Peter D White Journal: BMC Med Date: 2011-03-21 Impact factor: 8.775
Authors: Sara F Milrad; Daniel L Hall; Devika R Jutagir; Emily G Lattie; Gail H Ironson; William Wohlgemuth; Maria Vera Nunez; Lina Garcia; Sara J Czaja; Dolores M Perdomo; Mary Ann Fletcher; Nancy Klimas; Michael H Antoni Journal: J Neuroimmunol Date: 2016-12-14 Impact factor: 3.478
Authors: Mady Hornig; José G Montoya; Nancy G Klimas; Susan Levine; Donna Felsenstein; Lucinda Bateman; Daniel L Peterson; C Gunnar Gottschalk; Andrew F Schultz; Xiaoyu Che; Meredith L Eddy; Anthony L Komaroff; W Ian Lipkin Journal: Sci Adv Date: 2015-02 Impact factor: 14.136
Authors: Megan E Roerink; Hans Knoop; Sebastian J H Bredie; Michael Heijnen; Leo A B Joosten; Mihai G Netea; Charles A Dinarello; Jos W M van der Meer Journal: Trials Date: 2015-10-05 Impact factor: 2.279
Authors: D Peterson; E W Brenu; G Gottschalk; S Ramos; T Nguyen; D Staines; S Marshall-Gradisnik Journal: Mediators Inflamm Date: 2015-03-05 Impact factor: 4.711